ConductScience.org, home

Paper28736635

Immunotherapy in gastrointestinal cancers.

Grierson P and 2 others. J Gastrointest Oncol, 2017. Cited by 41 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunotherapy in gastrointestinal cancers. Papers, record 28736635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28736635

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunotherapy in gastrointestinal cancers.
PubMed
Journal
J Gastrointest Oncol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.25
iCite
Revised in PubMed
2020-09-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grierson PPatrick
2Lim KHKian-Huat
3Amin MManik

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120119674Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer.Ann Surg Oncol2010https://conductscience.org/library/papers/20119674PubMed
227376576Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.Nat Med2016https://conductscience.org/library/papers/27376576PubMed
326541610Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.Science2015https://conductscience.org/library/papers/26541610PubMed
412800259In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma.World J Gastroenterol2003https://conductscience.org/library/papers/12800259PubMed
525584002Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.J Clin Oncol2015https://conductscience.org/library/papers/25584002PubMed
612854132Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.World J Gastroenterol2003https://conductscience.org/library/papers/12854132PubMed
720333377Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma.Cancer Immunol Immunother2010https://conductscience.org/library/papers/20333377PubMed
827959684T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.N Engl J Med2016https://conductscience.org/library/papers/27959684PubMed
924163303Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study.Pathol Oncol Res2014https://conductscience.org/library/papers/24163303PubMed
1027412392Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.Oncologist2016https://conductscience.org/library/papers/27412392PubMed
1112820727MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment.Glycoconj J2001https://conductscience.org/library/papers/12820727PubMed
121574121Coley's toxins in perspective.Nature1992https://conductscience.org/library/papers/1574121PubMed
1316003736Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.Int J Cancer2006https://conductscience.org/library/papers/16003736PubMed
1419697355Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion.J Surg Oncol2009https://conductscience.org/library/papers/19697355PubMed
1518650514Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18650514PubMed
1615375495Fas ligand expression in human pancreatic cancer.Oncol Rep2004https://conductscience.org/library/papers/15375495PubMed
1710573518Cholangiocarcinomas express Fas ligand and disable the Fas receptor.Hepatology1999https://conductscience.org/library/papers/10573518PubMed
1812947224Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation.Immunol Res2003https://conductscience.org/library/papers/12947224PubMed
1923657083A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.Ann Surg2013https://conductscience.org/library/papers/23657083PubMed
2026541606Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.Science2015https://conductscience.org/library/papers/26541606PubMed

See all 45 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42201494Early Tumor Shrinkage and Clinical Outcomes for Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study.Ann Surg Oncol2026https://conductscience.org/library/papers/42201494PubMed
42098187PD-L1-positive circulating tumor cells associate with tumor malignancy and impaired circulating immunity in patients with gastrointestinal tumors.Sci Rep2026https://conductscience.org/library/papers/42098187PubMed
41710281Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).Immunotargets Ther2026https://conductscience.org/library/papers/41710281PubMed
41003004Paradoxical Regulation of α7nAChR and NLRP3 Inflammasome in Gastrointestinal Cancers and Ulcerative Colitis.Metabolites2025https://conductscience.org/library/papers/41003004PubMed
40211993Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers.Anticancer Agents Med Chem2025https://conductscience.org/library/papers/40211993PubMed
39001441Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases.Cancers (Basel)2024https://conductscience.org/library/papers/39001441PubMed
38994154Visualization analysis of research hotspots and trends on gastrointestinal tumor organoids.World J Gastrointest Oncol2024https://conductscience.org/library/papers/38994154PubMed
38533510Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.Front Immunol2024https://conductscience.org/library/papers/38533510PubMed
38421531Body Composition and Clinical Outcomes in Esophageal Cancer Patients Treated with Immune Checkpoint Inhibitors.Ann Surg Oncol2024https://conductscience.org/library/papers/38421531PubMed
38370364LncRNA-MUF: A Novel Oncogenic Star with Potential as a Biological Marker and Therapeutic Target for Gastrointestinal Malignancies.J Cancer2024https://conductscience.org/library/papers/38370364PubMed
37422529C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.Br J Cancer2023https://conductscience.org/library/papers/37422529PubMed
37373091Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors.Int J Mol Sci2023https://conductscience.org/library/papers/37373091PubMed
36599917Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer.Br J Cancer2023https://conductscience.org/library/papers/36599917PubMed
36261831Tumor buster - where will the CAR-T cell therapy 'missile' go?Mol Cancer2022https://conductscience.org/library/papers/36261831PubMed
36185433Coating bacteria for anti-tumor therapy.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36185433PubMed
35121724A Review of Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors of the Gastrointestinal Tract.Med Sci Monit2022https://conductscience.org/library/papers/35121724PubMed
33643302Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy.Front Immunol2020https://conductscience.org/library/papers/33643302PubMed
33176601RAI14 Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric Cancer.Technol Cancer Res Treat2020https://conductscience.org/library/papers/33176601PubMed
32772210TNM staging for GIT cancers is correlated with the level of MMPs and TGF-β1.Clin Exp Med2020https://conductscience.org/library/papers/32772210PubMed
32592066Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma.J Cancer Res Clin Oncol2020https://conductscience.org/library/papers/32592066PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28736635

GET https://conductscience.org/api/papers/v1/28736635/references?page=2